Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases

被引:20
作者
Nakamura, Haruhiko [1 ]
Saji, Hisashi [1 ]
Marushima, Hideki [1 ]
Kimura, Hiroyuki [1 ]
Tagaya, Rie [1 ]
Kurimoto, Noriaki [1 ]
Hoshikawa, Masahiro [2 ]
Takagi, Masayuki [2 ]
机构
[1] St Marianna Univ, Sch Med, Dept Chest Surg, Kawasaki, Kanagawa, Japan
[2] St Marianna Univ, Sch Med, Dept Pathol, Kawasaki, Kanagawa, Japan
关键词
POSITRON-EMISSION-TOMOGRAPHY; LIMITED RESECTION; RANDOMIZED-TRIAL; LOBECTOMY; SEGMENTECTOMY; ADENOCARCINOMA; RECURRENCE; SURVIVAL;
D O I
10.1245/s10434-015-4564-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. Maximum standardized uptake values (SUVmax) at the primary lesions of non-small-cell lung cancer in F-18-fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT), and the microscopic local extension of tumors were examined to develop reliable criteria to determine candidates for sublobar resection. Methods. We retrospectively analyzed 209 patients who underwent lobectomy, bilobectomy, or pneumonectomy with systematic lymph node dissection. Preoperative SUVmax at the primary lesion, microscopic lymphatic, venous, and pleural invasion in addition to lymph node metastases in the resected specimens were examined. Receiver operating characteristic analyses were used to predict an optimal cutoff for lymph node metastases. Results. With receiver operating characteristic analysis, the areas under the curve for SUVmax and tumor size were 0.693 and 0.545, respectively, suggesting SUVmax superiority for prediction of lymph node metastases with a cutoff of 2.9. When a tumor was <= 2.0 cm (n = 41, 19.6 %), the percentages of microscopic lymphatic invasion, venous invasion, pleural invasion, and lymph node metastases were 12.2, 7.3, 4.9, and 17.1 %, respectively. When SUVmax was <3.0 (n = 91, 43.5 %), these percentages were 15.4, 3.3, 7.7, and 8.8 %, showing that SUVmax could efficiently exclude nodal metastases in more cases than tumor size. The postoperative 5-year survival rate was 86.6 % in patients with SUVmax < 3.0 and 58.1 % in patients with SUVmax >= 3.0 (p < 0.001). Conclusions. F-18-FDG uptake value was more useful than tumor size for selecting patients with non-small-cell lung cancer suitable for intentional sublobar resection.
引用
收藏
页码:S1388 / S1393
页数:6
相关论文
共 27 条
[1]   Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer [J].
Al-Sarraf, Nael ;
Gately, Kathy ;
Lucey, Julie ;
Wilson, Lorraine ;
McGovern, Eillish ;
Young, Vincent .
CLINICAL LUNG CANCER, 2008, 9 (01) :39-43
[2]   Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy? [J].
Asamura, H ;
Nakayama, H ;
Kondo, H ;
Tsuchiya, R ;
Shimosato, Y ;
Naruke, T .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (06) :1125-1134
[3]  
Brown RS, 1999, J NUCL MED, V40, P556
[4]   Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria? [J].
Casiraghi, Monica ;
Travaini, Laura L. ;
Maisonneuve, Patrick ;
Tessitore, Adele ;
Brambilla, Daniela ;
Agoglia, Bernardo G. ;
Guarize, Juliana ;
Spaggiari, Lorenzo .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 39 (04) :E38-E43
[5]   Biological correlates of FDG uptake in non-small cell lung cancer [J].
de Geus-Oei, Lioe-Fee ;
van Krieken, J. Han J. M. ;
Aliredjo, Riena P. ;
Krabbe, Paul F. M. ;
Frielink, Cathelijne ;
Verhagen, Ad F. T. ;
Boerman, Otto C. ;
Oyen, Wim J. G. .
LUNG CANCER, 2007, 55 (01) :79-87
[6]  
Goldstraw P., 2009, IASLC Staging Manual in Thoracic Oncology, V1st
[7]   Lymph node staging in non-small cell lung cancer: Evaluation by [F-18]FDG positron emission tomography (PET) [J].
Guhlmann, A ;
Storck, M ;
Kotzerke, J ;
Moog, F ;
SunderPlassmann, L ;
Reske, SN .
THORAX, 1997, 52 (05) :438-441
[8]   Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging [J].
Gupta, NC ;
Tamim, WJ ;
Graeber, GG ;
Bishop, HA ;
Hobbs, GR .
CHEST, 2001, 120 (02) :521-527
[9]  
Higashi K, 2002, J NUCL MED, V43, P39
[10]   RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER [J].
HOLMES, CE ;
RUCKDESCHEL, JC ;
JOHNSTON, M ;
THOMAS, PA ;
DESLAURIERS, J ;
GROVER, FL ;
HILL, LD ;
FELD, R ;
GINSBERG, RJ ;
MOUNTAIN, CF ;
DZUIBAN, S ;
KIELY, M ;
MCKNEALLY, MF ;
MOORES, DWO ;
RAMNES, C ;
WAGNER, H ;
BUNN, P ;
CHU, H ;
DIENHART, D ;
HAZUKA, M ;
KINZIE, J ;
SORENSEN, J ;
VANCE, V ;
BRAUN, T ;
HOPEMAN, A ;
KANE, M ;
RUSS, P ;
WHITMAN, GJR ;
FALL, SM ;
HANSEN, DP ;
HENDERSON, RH ;
MONCRIEF, CL ;
PAULING, F ;
SIMS, J ;
TELL, D ;
WISELYCARR, S ;
ABERNATHY, CM ;
CLARK, DA ;
MCCROSKEY, B ;
MOORE, G ;
MOORE, F ;
MYERS, A ;
WHITE, M ;
BROOKS, RJ ;
BULL, M ;
JOHNSON, FB ;
NEIMYR, M ;
PAQUETTE, FR ;
SACCOMANNO, G ;
LAD, T .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :615-622